Why Your Immune System Struggles in Autumn: Vitamin D, Gut Health and What the Research Shows | NDS Nutrition
Share
Why Your Immune System Struggles in Autumn: Vitamin D, Gut Health and What the Research Shows
Every autumn the same pattern emerges: colds become more frequent, energy drops, mood shifts, and the body feels less resilient. This is not bad luck or inevitable. It is a predictable biological response to specific seasonal changes that most people in the UK are not addressing. Here is what is actually happening and what the evidence shows about supporting it.
The transition from summer to autumn in the UK triggers a set of physiological changes that systematically reduce immune function. Daylight hours shorten. Sun angle drops below the threshold required for vitamin D synthesis. Temperatures fall. People spend more time indoors in closer proximity to others. The gut microbiome, which responds directly to seasonal shifts in diet and light exposure, begins to alter its composition. And the immune system, 70 to 80% of which resides in and around the gut, reflects every one of those changes.
Understanding why this happens is the first step to addressing it meaningfully rather than reactively, once the cold is already established.
The autumn vitamin D cliff
Vitamin D is not simply a bone health nutrient. It is an immunomodulatory hormone that regulates the expression of over 200 genes involved in immune function, inflammation and pathogen defence. Vitamin D receptors are present on virtually every immune cell in the body, including T cells, B cells, natural killer cells and macrophages. When vitamin D is adequate, these cells function with full capacity. When it is not, the immune response is measurably impaired.
In the UK, the angle of the sun between October and March is too low to trigger the cutaneous synthesis of vitamin D regardless of how much time you spend outside. The UV-B radiation required simply does not reach the skin at sufficient intensity at latitudes above approximately 52 degrees north. This means that for six months of the year, the entire UK population is dependent on dietary sources and supplementation to maintain vitamin D status, and most people are not supplementing.
The UK Biobank finding (2025): a study of 36,258 participants found that those with severe vitamin D deficiency had a 33% higher rate of hospitalisation for respiratory tract infection compared to those with adequate levels. For each 10 nmol/L increase in vitamin D, the hospitalisation rate for respiratory tract infections fell by 4%. The dose-response relationship is clear and consistent.
The clinical evidence for vitamin D supplementation in respiratory infection prevention is now substantial. A meta-analysis of 25 RCTs including 11,321 participants found that vitamin D supplementation reduced the risk of acute respiratory tract infection by 11%, with stronger protective effects in those who were deficient at baseline. The protective effect was most pronounced in people taking daily or weekly doses rather than infrequent large boluses, which aligns with the physiological role of vitamin D as a hormone that requires consistent circulating levels rather than periodic spikes.
The gut microbiome and seasonal immunity
The connection between gut health and immune function is not a peripheral finding. Approximately 70 to 80% of the immune system is located in and around the gut, concentrated in the gut-associated lymphoid tissue that lines the intestinal wall. The composition of the gut microbiome directly shapes how effectively those immune cells function, how quickly they respond to pathogens, and how well they regulate the inflammatory response once a threat is detected.
The gut microbiome is not static. It responds to diet, stress, sleep, physical activity, antibiotic use and, increasingly, the research suggests, seasonal changes in light exposure and temperature. Autumn and winter are associated with dietary shifts toward less diverse, more processed foods and away from the fresh vegetables and fermented foods that support microbiome diversity. The combination of reduced dietary diversity, less physical activity and higher stress is a reliable recipe for gut dysbiosis, and gut dysbiosis directly undermines the immune competence that depends on a healthy, diverse microbial community.
Research published in Mathematical Medicine and Biology (2024) developed a mathematical model describing the interactions between the microbiota, the vitamin D receptor pathway, the epithelial barrier and immune response. The model confirmed that combined supplementation with vitamin D and probiotics is superior to either alone or placebo, a finding consistent with a systematic review that recommended their combination specifically.
The mechanism is bidirectional: specific probiotic strains increase circulating vitamin D levels and induce vitamin D receptor expression in the gut mucosa, while vitamin D in turn enhances the immunomodulatory and anti-inflammatory effects of probiotics. The two interventions amplify each other in ways that neither achieves independently.
Key implication: autumn immune support is most effectively approached as a combination protocol - vitamin D to address the seasonal deficiency that impairs immune cell function, and targeted probiotics to maintain the gut microbiome diversity on which immune competence depends.
What happens to immune function in autumn without intervention
The role of vitamin D in immunity - beyond the basics
The NHS recommends vitamin D supplementation for all UK adults from October to March. The recommended dose is 10 micrograms (400 IU) daily. This is a floor, not a target - it is the minimum dose required to prevent clinical deficiency, not the dose associated with optimal immune function in clinical trials, which typically uses 1,000 to 2,000 IU daily in otherwise healthy adults.
Vitamin D deficiency affects between 20 and 40% of the UK population, with higher rates in older adults, where prevalence among those over 65 reaches 54.8%, and in individuals with darker skin, where rates exceed 70%. These groups are at highest risk during autumn and winter and represent the population in whom vitamin D supplementation has the most consistent and meaningful impact on respiratory infection outcomes.
The form of vitamin D matters as much as the dose. Vitamin D3 (cholecalciferol) is the form produced by the skin and is more effective at raising and maintaining 25(OH)D serum levels than D2 (ergocalciferol). Food state vitamin D3, presented within a whole food matrix, is absorbed and utilised more effectively than isolated synthetic D3, which must be modified by the body before it can interact with vitamin D receptors.
Probiotic strains for autumn immune support
Not all probiotic strains contribute equally to immune function. The evidence base for specific strains in respiratory infection prevention and immune regulation is now substantial enough to be selective about which strains are relevant for an autumn immune protocol.
A Cochrane systematic review confirmed that Lactobacillus and Bifidobacterium species reduce the incidence and duration of acute upper respiratory tract infections. Lactobacillus rhamnosus has the strongest individual evidence base for reducing respiratory infection frequency and severity. Bifidobacterium lactis has documented effects on natural killer cell activity and antibody production, two components of the immune response that are directly relevant to viral defence. L. paracasei and L. acidophilus contribute to gut barrier integrity and reduce the systemic inflammatory load that diverts immune resources.
The delivery method matters. Probiotic bacteria in powder form, dissolved in water before consumption, survive passage through the stomach in significantly higher numbers than the equivalent bacteria in a capsule or tablet arriving dry in the gastric environment. More viable bacteria reaching the intestine means more meaningful modulation of the immune environment that resides there.
Medicinal mushrooms and autumn immune support
The traditional use of medicinal mushrooms for immune support in autumn and winter reflects an intuitive understanding of seasonal vulnerability that predates clinical science by centuries. The research now provides the mechanistic explanation for what practitioners observed empirically.
Beta-glucans, the primary bioactive polysaccharides in medicinal mushroom fruiting bodies, are among the most studied natural immune modulators. They interact with pattern recognition receptors on macrophages, natural killer cells and dendritic cells, priming the innate immune response and enhancing the speed and effectiveness of the response to pathogen challenge. Unlike direct immune stimulants that can tip the immune system into hyperactivity, beta-glucans act as biological response modifiers, calibrating the immune response toward appropriate, measured activity rather than excessive inflammation.
Reishi contains triterpenoids alongside beta-glucans that have documented anti-inflammatory, antiviral and adaptogenic properties. It is particularly relevant in autumn for its combined effects on immune modulation and stress response regulation, addressing two of the primary drivers of seasonal immune decline simultaneously. Chaga contains one of the highest known concentrations of superoxide dismutase, an antioxidant enzyme that reduces the oxidative stress associated with both infection and chronic inflammation. Shiitake contains lentinan, a specific beta-glucan with particularly well-documented effects on natural killer cell activity and macrophage activation.
The majority of clinical research on medicinal mushrooms uses whole fruiting body extracts rather than mycelium-only products. The fruiting body contains the full spectrum of beta-glucans, triterpenoids and polysaccharides that are responsible for the documented immune effects. Mycelium products often contain significant quantities of the grain substrate on which the mycelium was grown, diluting the concentration of active compounds. NDS mushroom biomass products use whole fruiting body material, ensuring the beta-glucan and triterpenoid concentrations that match the clinical evidence.
An autumn immune protocol - what the evidence supports
- Vitamin D3 from October through March. Begin supplementation at the start of October without waiting for symptoms. 1,000 to 2,000 IU daily is the dose range associated with immune benefit in clinical trials. Food state D3 improves absorption and utilisation versus isolated synthetic forms. Take alongside vitamin K2 which directs calcium appropriately and supports the cardiovascular safety of higher D3 doses
- Targeted probiotic supplementation. Strains selected for immune modulation including L. rhamnosus, B. lactis and L. acidophilus. Consistent daily use is more effective than intermittent use. Powder form for maximum bacterial viability. Start in September before the respiratory virus season peaks
- Medicinal mushroom support. Reishi for combined immune modulation and stress response. Chaga for antioxidant and immune support. Shiitake for lentinan-specific natural killer cell activation. Whole fruiting body products to ensure the beta-glucan concentrations matching the clinical evidence
- Maintain dietary diversity. A diverse, plant-rich diet provides the prebiotic fibre substrate that allows probiotic bacteria to colonise and produce the short-chain fatty acids that maintain gut barrier integrity. The autumn shift toward more processed, less diverse foods is itself an immune risk factor that nutrition choices can counteract
- Prioritise sleep. Sleep is the primary window for immune regulation and inflammatory clearance. Seven to nine hours of quality sleep is a direct immune intervention, not a lifestyle luxury. Reishi's adaptogenic effects on stress and sleep quality make it particularly relevant for the combination of seasonal immune and sleep pressure that autumn produces
Honest framing
Vitamin D supplementation, targeted probiotic strains and medicinal mushroom beta-glucans all have documented effects on immune function and respiratory infection risk. None of them prevents all infections. The evidence supports a meaningful reduction in risk and severity, not complete immunity. The effect of vitamin D is strongest in those who are deficient at baseline, which given UK prevalence rates means the majority of adults entering autumn without supplementation. Anyone with a known immune condition, those taking immunosuppressant medication, and those who are pregnant or breastfeeding should discuss supplementation with a GP or qualified practitioner before starting.
Frequently asked questions
When should I start taking vitamin D in the UK?
October is the practical starting point, when UV-B levels in the UK drop below the threshold required for cutaneous vitamin D synthesis. The NHS recommends supplementation from October to March for all adults. Starting earlier in September gives circulating levels time to rise before the peak respiratory virus season in November and December.
Can I take vitamin D and probiotics together?
Yes, and the evidence suggests their combination is superior to either alone. Research confirms bidirectional enhancement: specific probiotic strains increase vitamin D receptor expression in the gut, while vitamin D enhances the immunomodulatory effects of probiotics. Taking both as part of an autumn protocol addresses the two primary mechanisms of seasonal immune decline simultaneously.
Are medicinal mushrooms safe to take daily?
Medicinal mushrooms including Reishi, Chaga and Shiitake have long histories of daily use in traditional clinical practice and a good safety profile in modern research at standard doses. As with any supplement, those with autoimmune conditions, those taking blood-thinning or immunosuppressant medication, and those who are pregnant should consult a healthcare practitioner before starting.
How long before I notice immune benefits from probiotics?
Clinical studies on probiotic immune effects typically use 8 to 12 week intervention periods. Starting in September or early October means the microbiome shifts that support immune competence are established before the peak of the winter respiratory virus season. This is why timing matters: starting reactively, once you are already ill, is less effective than building a resilient gut microbiome proactively.
NDS offers food state vitamin D3, strain-specific probiotics formulated for immune and gut health, and whole fruiting body mushroom biomass products. All formulated to the practitioner standard that maximises the bioavailability of every active ingredient.
Explore the NDS range →Sources: Bournot et al. (2025) Association between serum 25-hydroxyvitamin D status and respiratory tract infections, UK Biobank 36,258 participants, University of Reading; Moncy and Elshenawy (2025) Vitamin D deficiency affects 20-40% of UK population, University of Hertfordshire; Meta-analysis of 25 RCTs, 11,321 participants, vitamin D supplementation and acute respiratory tract infection risk, Public Health Nutrition (2024); Franks et al. (2024) Modelling the influence of vitamin D and probiotic supplementation on the microbiome and immune response, Mathematical Medicine and Biology; International Consensus Statement on Vitamin D and immune tolerance, Reviews in Endocrine and Metabolic Disorders (2026); Cochrane Database of Systematic Reviews (2022) Probiotics for preventing acute upper respiratory tract infections; NIH ODS Probiotics Health Professional Fact Sheet (2026); Circannual prevalence of vitamin D insufficiency in older adults in Northern Britain, medrxiv (2025).